Aubrey De Grey breaks down longevity escape velo

Longevity biotech investment in 2026 is no longe

Researchers use AI to redesign antibody fragment

At AMWC Monaco, Allergan Aesthetics says the fut

New research shows that type 2 diabetes and wors

Alterity Therapeutics received positive feedback

With just weeks to go, the UK’s defining event

New Longevity Show blog explores how clinics are

New partnership brings early cognitive screening

Coordinated demonstrations across 14 cities set

$2.

Allergan Aesthetics, an AbbVie company, positione

Insilico Medicine and Tenacia Biotechnology are e

BCC Research has published a Pulse research title

Research projects the global cell therapy manufac

Phase 1 data suggest senotherapeutic activity in

Novo Nordisk’s higher-dose semaglutide arrives

Human Longevity and LEV Foundation will study ce

Cellbricks Therapeutics has raised €10 million

Alina M Hernandez and Nigel Franklyn on why long

Maze Therapeutics announced positive topline Phas

Human Longevity, Inc.

Rubedo Life Sciences reported preliminary Phase 1

Fresh funding backs a high-stakes attempt to do

SEMCAP is betting that longevity’s next growth

Immortal Dragons-backed Unlimited Bio registers

New data link popular weight-loss drugs to highe

Deal worth up to $150m comes as supplementation

20/20 BioLabs has entered an exclusive U.S.

20/20 BioLabs has entered an exclusive U.S.

Anavex Life Sciences withdrew its marketing autho

Cognito Therapeutics and Ochsner Health have laun

SpectraCell Laboratories introduced Baseline Nexu

Roatán-based longevity clinic adds Klotho to it

Combined company targets mitochondrial biology a

Cognito and Ochsner join forces to explore how c

As longevity biotech scales, new AI tools target

Fresh Alzheimer’s theory gives investors new l

New profiling tech looks beyond which microbes l

Longevity Medical Institute’s new paper adds w

Celosia Therapeutics announced on 23 March 2026,

C2N Diagnostics reported the first application of

Nanoscope Therapeutics announced publication of a

Annovis has partnered with NeuroRPM to deploy an

Alnylam is launching coordinated initiatives to a

Preprint RCT in healthy adults suggests multi-ta

Partners expand beyond initial sarcopenia progra

New tool harnesses data from multiple sources to

New preclinical data suggest Galimedix may have

Company aims to give AI much broader map of life